These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 37990852)

  • 41. Ag-Doped and Antibiotic-Loaded Hexagonal Boron Nitride Nanoparticles as Promising Carriers to Fight Different Pathogens.
    Gudz KY; Antipina LY; Permyakova ES; Kovalskii AM; Konopatsky AS; Filippovich SY; Dyatlov IA; Slukin PV; Ignatov SG; Shtansky DV
    ACS Appl Mater Interfaces; 2021 May; 13(20):23452-23468. PubMed ID: 34000197
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Internal stimuli-responsive nanocarriers for controlled anti-cancer drug release: a review.
    Shaik BB; Katari NK; Jonnalagadda SB
    Ther Deliv; 2023 Sep; 14(9):595-613. PubMed ID: 37877308
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antibiotic-free nanotherapeutics: ultra-small, mucus-penetrating solid lipid nanoparticles enhance the pulmonary delivery and anti-virulence efficacy of novel quorum sensing inhibitors.
    Nafee N; Husari A; Maurer CK; Lu C; de Rossi C; Steinbach A; Hartmann RW; Lehr CM; Schneider M
    J Control Release; 2014 Oct; 192():131-40. PubMed ID: 24997276
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Silica-Based Nanoparticles for Biomedical Applications: From Nanocarriers to Biomodulators.
    Yang Y; Zhang M; Song H; Yu C
    Acc Chem Res; 2020 Aug; 53(8):1545-1556. PubMed ID: 32667182
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Reactive oxygen species stimuli-responsive nanocarriers].
    Zhou W; Yang K; Zhao B; Zhang L; Zhang Y
    Se Pu; 2021 Feb; 39(2):118-124. PubMed ID: 34227343
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Advances in 'Trojan horse' strategies in antibiotic delivery systems.
    Dassonville-Klimpt A; Sonnet P
    Future Med Chem; 2020 Jun; 12(11):983-986. PubMed ID: 32270702
    [No Abstract]   [Full Text] [Related]  

  • 47. Organ-restricted delivery through stimuli-responsive nanocarriers for lung cancer therapy.
    Dinakar YH; Karole A; Parvez S; Jain V; Mudavath SL
    Life Sci; 2022 Dec; 310():121133. PubMed ID: 36306866
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Recent advances in the treatment of pathogenic infections using antibiotics and nano-drug delivery vehicles.
    Van Giau V; An SSA; Hulme J
    Drug Des Devel Ther; 2019; 13():327-343. PubMed ID: 30705582
    [TBL] [Abstract][Full Text] [Related]  

  • 49. CaP coated mesoporous polydopamine nanoparticles with responsive membrane permeation ability for combined photothermal and siRNA therapy.
    Wang Z; Wang L; Prabhakar N; Xing Y; Rosenholm JM; Zhang J; Cai K
    Acta Biomater; 2019 Mar; 86():416-428. PubMed ID: 30611792
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Fabrication of biodegradable Mn-doped mesoporous silica nanoparticles for pH/redox dual response drug delivery.
    Li X; Zhang X; Zhao Y; Sun L
    J Inorg Biochem; 2020 Jan; 202():110887. PubMed ID: 31670257
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nano-fats for bugs: the benefits of lipid nanoparticles for antimicrobial therapy.
    Thorn CR; Thomas N; Boyd BJ; Prestidge CA
    Drug Deliv Transl Res; 2021 Aug; 11(4):1598-1624. PubMed ID: 33675007
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Aerosol-Assisted Synthesis of Tailor-Made Hollow Mesoporous Silica Microspheres for Controlled Release of Antibacterial and Anticancer Agents.
    Poostforooshan J; Belbekhouche S; Shaban M; Alphonse V; Habert D; Bousserrhine N; Courty J; Weber AP
    ACS Appl Mater Interfaces; 2020 Feb; 12(6):6885-6898. PubMed ID: 31967774
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nanocarriers as versatile delivery systems for effective management of acne.
    Patel R; Prabhu P
    Int J Pharm; 2020 Apr; 579():119140. PubMed ID: 32061843
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Stimuli-responsive polymeric nanocarriers for the controlled transport of active compounds: concepts and applications.
    Fleige E; Quadir MA; Haag R
    Adv Drug Deliv Rev; 2012 Jun; 64(9):866-84. PubMed ID: 22349241
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Controlled drug release from lung-targeted nanocarriers via chemically mediated shell permeabilisation.
    Chen H; Woods A; Forbes B; Jones S
    Int J Pharm; 2016 Sep; 511(2):1033-41. PubMed ID: 27506512
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Carbohydrates based stimulus responsive nanocarriers for cancer-targeted chemotherapy: a review of current practices.
    Zhang CW; Zhang JG; Yang X; Du WL; Yu ZL; Lv ZY; Mou XZ
    Expert Opin Drug Deliv; 2022 Jun; 19(6):623-640. PubMed ID: 35611662
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Smart Dual-Stimuli Responsive Nanoparticles for Controlled Anti-Tumor Drug Release and Cancer Therapy.
    Wu F; Qiu F; Wai-Keong SA; Diao Y
    Anticancer Agents Med Chem; 2021; 21(10):1202-1215. PubMed ID: 32972353
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Reactive oxygen species responsive nanoplatforms as smart drug delivery systems for gastrointestinal tract targeting.
    Bertoni S; Machness A; Tiboni M; Bártolo R; Santos HA
    Biopolymers; 2020 Jan; 111(1):e23336. PubMed ID: 31724750
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Impact of the strategy adopted for drug loading in nonporous silica nanoparticles on the drug release and cytotoxic activity.
    Riva B; Bellini M; Corvi E; Verderio P; Rozek E; Colzani B; Avvakumova S; Radeghieri A; Rizzuto MA; Morasso C; Colombo M; Prosperi D
    J Colloid Interface Sci; 2018 Jun; 519():18-26. PubMed ID: 29477896
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prodrug-based nanoparticulate drug delivery strategies for cancer therapy.
    Luo C; Sun J; Sun B; He Z
    Trends Pharmacol Sci; 2014 Nov; 35(11):556-66. PubMed ID: 25441774
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.